BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jiang S, Meng L, Chen X, Liu H, Zhang J, Chen F, Zheng J, Liu H, Wang F, Hu J, Li Z. MEX3A promotes triple negative breast cancer proliferation and migration via the PI3K/AKT signaling pathway. Experimental Cell Research 2020;395:112191. [DOI: 10.1016/j.yexcr.2020.112191] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhou X, Li S, Ma T, Zeng J, Li H, Liu X, Li F, Jiang B, Zhao M, Liu Z, Qin Y. MEX3A knockdown inhibits the tumorigenesis of colorectal cancer via modulating CDK2 expression. Exp Ther Med 2021;22:1343. [PMID: 34630697 DOI: 10.3892/etm.2021.10778] [Reference Citation Analysis]
2 Wang Y, Liang Q, Lei K, Zhu Q, Zeng D, Liu Y, Lu Y, Kang T, Tang N, Huang L, Ye L, Tang D, Zhu C. Targeting MEX3A attenuates metastasis of breast cancer via β-catenin signaling pathway inhibition. Cancer Lett 2021;521:50-63. [PMID: 34425185 DOI: 10.1016/j.canlet.2021.08.022] [Reference Citation Analysis]
3 Lederer M, Müller S, Glaß M, Bley N, Ihling C, Sinz A, Hüttelmaier S. Oncogenic Potential of the Dual-Function Protein MEX3A. Biology (Basel) 2021;10:415. [PMID: 34067172 DOI: 10.3390/biology10050415] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Yan L, Li H, An W, Wei W, Zhang X, Wang L. Mex-3 RNA binding MEX3A promotes the proliferation and migration of breast cancer cells via regulating RhoA/ROCK1/LIMK1 signaling pathway. Bioengineered 2021;12:5850-8. [PMID: 34486491 DOI: 10.1080/21655979.2021.1964155] [Reference Citation Analysis]
5 Mir C, Garcia-Mayea Y, LLeonart ME. Targeting the "undruggable": RNA-binding proteins in the spotlight in cancer therapy. Semin Cancer Biol 2022:S1044-579X(22)00152-3. [PMID: 35772609 DOI: 10.1016/j.semcancer.2022.06.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Sun H, Dai J, Chen M, Chen Q, Xie Q, Zhang W, Li G, Yan M. miR-139-5p Was Identified as Biomarker of Different Molecular Subtypes of Breast Carcinoma. Front Oncol 2022;12:857714. [DOI: 10.3389/fonc.2022.857714] [Reference Citation Analysis]
7 Li H, Liang J, Wang J, Han J, Li S, Huang K, Liu C. Mex3a promotes oncogenesis through the RAP1/MAPK signaling pathway in colorectal cancer and is inhibited by hsa-miR-6887-3p. Cancer Commun (Lond) 2021;41:472-91. [PMID: 33638620 DOI: 10.1002/cac2.12149] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Oshi M, Newman S, Murthy V, Tokumaru Y, Yan L, Matsuyama R, Endo I, Takabe K. ITPKC as a Prognostic and Predictive Biomarker of Neoadjuvant Chemotherapy for Triple Negative Breast Cancer. Cancers (Basel) 2020;12:E2758. [PMID: 32992708 DOI: 10.3390/cancers12102758] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
9 Jiang Z, Sun Z, Hu J, Li D, Xu X, Li M, Feng Z, Zeng S, Mao H, Hu C. Grass Carp Mex3A Promotes Ubiquitination and Degradation of RIG-I to Inhibit Innate Immune Response. Front Immunol 2022;13:909315. [DOI: 10.3389/fimmu.2022.909315] [Reference Citation Analysis]
10 Shi X, Sun Y, Zhang Y, Wang W, Xu J, Guan Y, Ding Y, Yao Y. MEX3A promotes development and progression of breast cancer through regulation of PIK3CA. Exp Cell Res 2021;404:112580. [PMID: 33811903 DOI: 10.1016/j.yexcr.2021.112580] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]